Peijia Medical Limited filed its monthly return for the period ended 31 March 2026, confirming a stable capital structure with no changes to authorised, issued or treasury shares during the month.

The company’s authorised share capital held steady at 1.00 billion ordinary shares with a par value of USD 0.0001 each, equivalent to total authorised capital of USD 0.10 million.

Issued share capital also remained unchanged at 672.06 million ordinary shares, and Peijia reported no treasury shares on hand. The Exchange-mandated public-float threshold of 25 per cent was met as of 31 March 2026.

No share options were granted, exercised, cancelled or lapsed in March. Outstanding options totalled 34.00 million, split between the Share Option Plan (29.43 million) and the Share Option Scheme (4.57 million). A further 56.43 million shares are available for future grants under the latter scheme. There were no warrants, convertible securities, Hong Kong Depositary Receipts, or other equity arrangements outstanding or transacted during the month.

The filing indicates that Peijia’s equity structure and shareholder base remained unchanged throughout March 2026, with full compliance confirmed against Hong Kong Listing Rule public-float requirements.